tiprankstipranks
Trending News
More News >
PaxMedica, Inc. (PXMD)
OTHER OTC:PXMD
US Market

PaxMedica, Inc. (PXMD) Price & Analysis

Compare
74 Followers

PXMD Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.65%0.71%99.29%
Mutual Funds
0.71% Other Institutional Investors
99.29% Public Companies and
Individual Investors

PXMD FAQ

What was PaxMedica, Inc.’s price range in the past 12 months?
PaxMedica, Inc. lowest stock price was $0.03 and its highest was $0.32 in the past 12 months.
    What is PaxMedica, Inc.’s market cap?
    PaxMedica, Inc.’s market cap is $1.09K.
      When is PaxMedica, Inc.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were PaxMedica, Inc.’s earnings last quarter?
      Currently, no data Available
      Is PaxMedica, Inc. overvalued?
      According to Wall Street analysts PaxMedica, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does PaxMedica, Inc. pay dividends?
        PaxMedica, Inc. does not currently pay dividends.
        What is PaxMedica, Inc.’s EPS estimate?
        PaxMedica, Inc.’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does PaxMedica, Inc. have?
        PaxMedica, Inc. has 10,879,170 shares outstanding.
          What happened to PaxMedica, Inc.’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of PaxMedica, Inc.?
          Currently, no hedge funds are holding shares in PXMD

          Company Description

          PaxMedica, Inc.

          PaxMedica, Inc. (PXMD) is a clinical-stage biopharmaceutical company focused on developing innovative therapies to address unmet needs in the field of neurodevelopmental disorders and other central nervous system conditions. The company's primary focus is on the development and commercialization of novel treatments, with its lead product candidate aimed at treating autism spectrum disorder (ASD) and other related conditions.
          Similar Stocks
          Company
          Price & Change
          Follow
          MannKind
          Neurocrine
          Anavex Life Sciences
          Bioxcel Therapeutics
          Shuttle Pharmaceuticals Holdings, Inc.
          Popular Stocks
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis